CIK 0001840877 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Envoy Medical, Inc.
Sign in to watch- Ticker
- COCH
- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 861369123
- Phone
- 651-361-8000
- Business address
- 4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE, MN, 55110
- Former names
- Anzu Special Acquisition Corp I
Securities
- COCH Class A Common Stock Nasdaq
- COCHW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-12 | Lucas Brent T. Chief Executive Officer | Purchase | +62,500 | $0.40 | $25K | 297,090 |
| 2026-02-12 | Lucas Brent T. Chief Executive Officer | Purchase · Warrant (right to buy) | +37,500 | 37,500 | ||
| 2026-02-12 | Lucas Brent T. Chief Executive Officer | Purchase · Warrant (right to buy) | +62,500 | 62,500 | ||
| 2026-02-05 | Potashnick Robert Interim CFO | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2026-02-05 | Lucas Brent T. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2025-12-03 | Smith-Gomez Janis Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-12-03 | Crowe Michael Curtis Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-12-03 | Patel Mona Chetan Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-12-03 | Kantor Susan Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2025-12-03 | BRYNELSEN CHARLES Director | Grant or award · Stock Option (right to buy) | +62,500 | 62,500 | ||
| 2025-11-28 | Lucas Brent T. Chief Executive Officer | Grant or award | +18,105 | $0.71 | $13K | 234,590 |
| 2025-09-04 | TAYLOR GLEN A Director | Returned to the company · Warrant (right to buy) | −500,000 | 0 | ||
| 2025-09-04 | TAYLOR GLEN A Director | Grant or award · Warrant (right to buy) | +500,000 | 500,000 | ||
| 2025-09-04 | TAYLOR GLEN A Director | Returned to the company · Warrant (right to buy) | −250,000 | 0 | ||
| 2025-09-04 | TAYLOR GLEN A Director | Grant or award · Warrant (right to buy) | +250,000 | 250,000 | ||
| 2025-09-04 | TAYLOR GLEN A Director | Returned to the company · Warrant (right to buy) | −250,000 | 0 | ||
| 2025-09-04 | TAYLOR GLEN A Director | Grant or award · Warrant (right to buy) | +250,000 | 250,000 | ||
| 2025-09-04 | TAYLOR GLEN A Director | Returned to the company · Warrant (right to buy) | −500,000 | 0 | ||
| 2025-09-04 | TAYLOR GLEN A Director | Grant or award · Warrant (right to buy) | +500,000 | 500,000 | ||
| 2025-09-04 | TAYLOR GLEN A Director | Returned to the company · Warrant (right to buy) | −500,000 | 0 |
Page 2 of 6 · 103 trades